TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
The activation and fusion of macrophages and of osteoclasts require the adaptor molecule DNAX-activating protein of 12 kD (DAP12), which contains immunoreceptor tyrosine-based activation motifs (ITAMs). TREM2 (triggering receptor expressed on myeloid cells-2) is the main DAP12-associated receptor in osteoclasts and, similar to DAP12 deficiency, loss of TREM2 in humans leads to Nasu-Hakola disease, which is characterized by bone cysts and dementia. Furthermore, in vitro experiments have shown that deficiency in DAP12 or TREM2 leads to impaired osteoclast development and the formation of mononuclear osteoclasts. Here, we demonstrate that the ligation of TREM2 activated phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase 1 (ERK1) and ERK2, and the guanine nucleotide exchange factor Vav3; induced the mobilization of intracellular calcium (Ca(2+)) and the reorganization of actin; and prevented apoptosis. The signaling adaptor molecule DAP10 played a key role in the TREM2- and DAP12-dependent recruitment of PI3K to the signaling complex. Src homology 2 (SH2) domain-containing inositol phosphatase-1 (SHIP1) inhibited TREM2- and DAP12-induced signaling by binding to DAP12 in an SH2 domain-dependent manner and preventing the recruitment of PI3K to DAP12. These results demonstrate a previously uncharacterized interaction of SHIP1 with DAP12 that functionally limits TREM2- and DAP12-dependent signaling and identify a mechanism through which SHIP1 regulates key ITAM-containing receptors by directly blocking the binding and activation of PI3K.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, SHIP1 inhibits phagocytic signal transduction by triggering receptor expressed on myeloid cells 2 (TREM2) and tyrosine kinase binding protein (TYROBP, also known as DAP12).11”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“INPP5D inhibits triggering receptor expressed on myeloid cell 2 (TREM2) signaling by sterically blocking the site where tyrosine-protein kinase (SYK) binds to tyrosine kinase-binding protein (TYROBP), the TREM2 adaptor protein, 10”
From INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“INPP5D negatively regulates signaling via several microglial cell surface receptors, including triggering receptor expressed on myeloid cells 2 (TREM2)”
From INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies support the hypothesis that SHIP1 negatively regulates microglia and macrophage phagocytosis, likely through its proposed regulation of TREM2 and TLR4, as well as Fc gamma receptor (FCγR) and complement receptor 3 (CR3)-mediated signaling, and potentially of other signaling pathways [106, 114, 121, 134–138].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is an activating receptor of the Ig-superfamily that binds lipids and transmits intracellular signals through the adaptor DAP12 (Peng et al., 2010; Ulland et al., 2017).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Peng et al., 2010
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., et al. (2004) · Nature · doi:10.1038/nature02444 · Cited by 828
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688
Mócsai, A., Humphrey, M. B., Van Ziffle, J. A. G., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S., Lanier, L. L., Lowell, C. A., & Nakamura, M. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401602101 · Cited by 463
Self-citationHamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440
Self-citationNKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., & Leibson, P. J. (2003) · Nature Immunology · doi:10.1038/ni929 · Cited by 374
Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation
Pasquier, B., Launay, P., Kanamaru, Y., Moura, I. C., Pfirsch, S., Ruffié, C., Hénin, D., Benhamou, M., Pretolani, M., Blank, U., et al. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.017 · Cited by 346
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice
Kaifu, T., Nakahara, J., Inui, M., Mishima, K., Momiyama, T., Kaji, M., Sugahara, A., Koito, H., Ujike-Asai, A., Nakamura, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16923 · Cited by 343
DAP10‐ and DAP12‐associated receptors in innate immunity
Lanier, L. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00720.x · Cited by 323
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12
Hamerman, J. A., Tchao, N. K., Lowell, C. A., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1204 · Cited by 318
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318
Research works printed but not linked: 1
- 10.4049/jimmunol.177.6.3520 · DOI · Paper page
Cited by
Items 401–447 of 447
Ocañas, S. R., Pham, K. D., Cox, J. E. J., Keck, A. W., Ko, S.-H., Ampadu, F. A., Porter, H. L., Ansere, V. A., Kulpa, A. M., Kellogg, C. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23972885
Ocañas, S. R., Pham, K. D., Cox, J. E. J., Keck, A. W., Ko, S.-H., Ampadu, F. A., Porter, H. L., Ansere, V. A., Kulpa, A. M., Kellogg, C. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23972870
Ye, S., Wu, C., Wang, Q., Huang, S., Fan, H., Chen, J., Xu, Y., & Ge, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4883991
The Characteristics and Function of Disease-Associated Microglia Related to Alzheimer’s Disease
Zhang, R. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au30136
Thakore, S. M. (2012) · Summit (Simon Fraser University)
Henderson, J. W. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.112765
Ocañas, S. R., Pham, K. D., Cox, J. E. J., Keck, A. W., Ko, S., Ampadu, F. A., Porter, H. L., Ansere, V. A., Kulpa, A. M., Kellogg, C. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23972861
Hu, M., Lin, Y., Men, X., Wang, S., Sun, X., Zhu, Q., Lu, D., Liu, S., Zhang, B., Cai, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14404328
Kapser, F. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-41385
Ocañas, S. R., Pham, K. D., Cox, J. E. J., Keck, A. W., Ko, S., Ampadu, F. A., Porter, H. L., Ansere, V. A., Kulpa, A. M., Kellogg, C. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23972855
Natunen, T., Martiskainen, H., Marttinen, M., Gabbouj, S., Koivisto, H., Kemppainen, S., Kaipainen, S., Takalo, M., Svobodová, H., Leppänen, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13213043
Pang, Y., Zhang, L., Zhong, Z., Yang, N., Zheng, Y., & Weijun, D. (2024) · Figshare · doi:10.6084/m9.figshare.26757238
Ocañas, S. R., Pham, K. D., Cox, J. E. J., Keck, A. W., Ko, S., Ampadu, F. A., Porter, H. L., Ansere, V. A., Kulpa, A. M., Kellogg, C. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23972864
Ocañas, S. R., Pham, K. D., Cox, J. E. J., Keck, A. W., Ko, S., Ampadu, F. A., Porter, H. L., Ansere, V. A., Kulpa, A. M., Kellogg, C. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23972852
Belboul, A. (2024) · e-space (Manchester Metropolitan University)
Investigating the role of microglia risk genes in Alzheimer’s disease
Vassileva, M. (2023) · ORCA Online Research @Cardiff (Cardiff University)
Sylvia, C. T. Y. (2016) · cIRcle (University of British Columbia)
The TREM2 Receptor Directs Microglial Activity in Neurodegeneration and Neurodevelopment
Jay, T. R. (2019) · OhioLink ETD Center (Ohio Library and Information Network)
Re-educating macrophages to activate antitumor immunity: One Clever Immunotherapy
Viitala, M. (2023) · UTUPub (University of Turku)
The Impact of INPP5D on Microglia Response to Tau Pathology in Alzheimer's Disease
Soni, D. (2025) · IUScholarWorks (Indiana University) · doi:10.7912/ga1a-ga83
Modulation of Macrophage Phenotype by Platelets and Cyclophilin A in Cardiovascular Inflammation
Rosa, A. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-37533
The Role of INPP5D in Microglial Function and Amyloid Pathogenesis
Lin, P. B. (2023) · IUScholarWorks (Indiana University) · doi:10.7912/yxj0-rn10
CARD9 orchestrates tissue damage in APAP-induced hepatitis via TREM2-mediated sensing cell death
Yang, Z., Li, S., Lu, R., Wei, Z., Zhao, X., & Lin, X. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf222
Chen, Y., Wang, H., Wang, J., & Wei, J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112485
APOE4 and INPP5D converge on membrane mechanics to regulate endocytosis in human astrocytesPreprint
Gevorgyan, A. S., Gordon, L. M., Combs, C. A., Lita, A., Yang, L. G., Cuní‐López, C., Root, J. T., Larion, M., Taraska, J. W., & Narayan, P. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.726347
Molecular understanding and clinical aspects of adoptive cellular immunotherapy in prostate cancer
Du, X., Yan, Z., Su, P., Liang, H., Dong, D., & Wang, K. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105395
Chen, H., Fei, J., & Zhang, K. (2026) · Medicine · doi:10.1097/md.0000000000047870
The Cellular Mechanisms of Alzheimer's Disease Protection by the PILRA G78R Variant
Cheng, W. (2025) · ScholarsArchive (Brigham Young University)
Wu, X., Zhang, Y., Yang, Q., Xue, L., Guo, Y., Li, L., Liu, C., Jin, M., Pan, G., Men, J., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70567
Debray, H. Z., Cheng, D., Ayala, L. A., Lam, T., Shin, J., Nicholas, D., Inlay, M. A., Drayman, N., Edwards, R. A., & Lodoen, M. B. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014462
Decoding TREM2: A microglial receptor governing the fate of myelin
Zhang, Z., Zhang, W., Jin, L., Wei, C., Chen, H., 程相树, & Wei, J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112815
TREM2: A Potential Target for the Targeted Therapy of Metabolic Diseases
Li, Y., Liu, S. Q., Chu, C., & Yang, J. (2026) · Mediators of Inflammation · doi:10.1155/mi/6210178
TREM2-directed therapy in Alzheimer’s disease: from therapeutic window to clinical translation
Kuang, Q., Li, S., Huang, W., Kuang, N., Liu, T., Huang, N., Luo, Y., & Huang, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1938062
Dynamic Crosstalk Between TREM2+ Macrophages and the MASLD Hepatic Microenvironment
Li, X., Yu, C., Mao, A., Peng, Y., Yiyang, H., & Zhao, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14102167
Xu, J., Chang, Y., Liu, D., & Chen, C. (2026) · Neurology International · doi:10.3390/neurolint18100186
Lv, Y., Shi, M., Zhao, Y., Yu, Y., Jia, W., & Hai, Z. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70863
SHIP1 regulates TREM2 signalling and macrophage functions in a hiPSC ‐derived model
Martin, K. S., Obst, J., Ibarra, S., Murphy, E. J., Gospodinova, K., & Mead, E. (2026) · FEBS Journal · doi:10.1111/febs.70752
Martin, E., & Versées, W. (2026) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2026.2743893
Zheng, Y., Cheng, J., Li, F., Ren, Z., Chen, C., Zhang, Z., Lan, X., Zhang, C., Zhao, Y., Han, J., et al. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04916-2
BindingDB Entry 50023001: Discovery and evaluation of novel SHIP-1 inhibitors.
BindingDB (2026) · UC San Diego · doi:10.7270/q22z1bds
Sun, J., Gao, G., Wang, S., Li, S., Tang, J., Liu, H., & Tang, T.-S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02776-4
Lipid-immune interplay in chronic inflammatory-based disorders
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8967-0
Zhang, R., Pan, J., Ma, N., Tang, X., & Zhao, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.2008356
Zhang, Z., Tian, M., Wang, J., Ge, W., & Chen, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1957607
Zhang, T., & Sun, K. (2026) · Brain Sciences · doi:10.3390/brainsci16111239
Metadata
- Authors
- Peng, Q., Malhotra, S., Torchia, J. A., Kerr, W. G., Coggeshall, K. M., & Humphrey, M. B.
- Affiliations
- Jilin University (CN)
- University of Oklahoma Health Sciences Center (US)
- University of California, San Francisco (US)
- SUNY Upstate Medical University (US)
- Oklahoma Medical Research Foundation (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Humphrey, Mary Beth
- Venue
- Science Signaling
- Published
- 2010-05-18
- Volume
- 3
- Issue
- 122
- Pages
- ra38-ra38
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC2900152
- OpenAlex
- W2121590561
- Cited by
- 413
- References
- 55
- Citations by year
- 2026: 41 · 2025: 43 · 2024: 49 · 2023: 44 · 2022: 41 · 2021: 34 · 2020: 28 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 11 · 2015: 13 · 2014: 14 · 2013: 11 · 2012: 14
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL085580, R01HL085580, R01HL072523, HL72523)
- National Institute of Allergy and Infectious Diseases (U19AI062629)
- National Institute of Dental and Craniofacial Research (DE019398, R01DE019398)
- National Center for Research Resources (P20RR020143, P20 RR0201143)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- TREM2, DAP12, DAP10, SHIP1, PI3K activation, osteoclastogenesis, macrophage fusion, ERK signaling, Vav3, calcium mobilization, actin reorganization, apoptosis, Nasu-Hakola disease, SH2 domain binding, receptor signaling regulation
- MeSH terms
- Inositol Polyphosphate 5-Phosphatases, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Phosphoinositide-3 Kinase Inhibitors, Animals, Cell Division, Cell Line, Enzyme Activation, Membrane Glycoproteins, Mice, Inbred C57BL, Osteoclasts, Phosphoric Monoester Hydrolases, Phosphorylation, Receptors, Immunologic, Signal Transduction, src Homology Domains, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.